Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
243 |
1672 |
5.781e-33 |
2.69e-29 |
2 |
NEUROGENESIS |
213 |
1402 |
1.92e-31 |
4.466e-28 |
3 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
144 |
788 |
2.11e-29 |
2.455e-26 |
4 |
CIRCULATORY SYSTEM DEVELOPMENT |
144 |
788 |
2.11e-29 |
2.455e-26 |
5 |
TISSUE DEVELOPMENT |
217 |
1518 |
2.947e-28 |
2.743e-25 |
6 |
REGULATION OF CELL DIFFERENTIATION |
212 |
1492 |
3.172e-27 |
2.46e-24 |
7 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
174 |
1142 |
1.031e-25 |
6.854e-23 |
8 |
CELL DEVELOPMENT |
201 |
1426 |
2.518e-25 |
1.464e-22 |
9 |
REGULATION OF CELL DEVELOPMENT |
141 |
836 |
3.566e-25 |
1.843e-22 |
10 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
158 |
1021 |
4.585e-24 |
2.133e-21 |
11 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
129 |
750 |
7.345e-24 |
3.107e-21 |
12 |
VASCULATURE DEVELOPMENT |
96 |
469 |
1.727e-23 |
6.697e-21 |
13 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
193 |
1395 |
2.567e-23 |
9.188e-21 |
14 |
ORGAN MORPHOGENESIS |
137 |
841 |
5.238e-23 |
1.741e-20 |
15 |
HEART DEVELOPMENT |
93 |
466 |
5.7e-22 |
1.768e-19 |
16 |
REGULATION OF NEURON DIFFERENTIATION |
102 |
554 |
2.998e-21 |
8.72e-19 |
17 |
BLOOD VESSEL MORPHOGENESIS |
79 |
364 |
3.786e-21 |
9.901e-19 |
18 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
176 |
1275 |
3.83e-21 |
9.901e-19 |
19 |
INTRACELLULAR SIGNAL TRANSDUCTION |
203 |
1572 |
7.101e-21 |
1.739e-18 |
20 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
207 |
1618 |
8.337e-21 |
1.94e-18 |
21 |
BIOLOGICAL ADHESION |
151 |
1032 |
1.395e-20 |
3.091e-18 |
22 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
142 |
957 |
6.101e-20 |
1.234e-17 |
23 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
208 |
1656 |
5.921e-20 |
1.234e-17 |
24 |
RESPONSE TO ENDOGENOUS STIMULUS |
189 |
1450 |
7.174e-20 |
1.391e-17 |
25 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
146 |
1008 |
1.678e-19 |
3.07e-17 |
26 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
122 |
771 |
1.715e-19 |
3.07e-17 |
27 |
NEURON DIFFERENTIATION |
131 |
874 |
8.115e-19 |
1.398e-16 |
28 |
LOCOMOTION |
154 |
1114 |
1.366e-18 |
2.269e-16 |
29 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
214 |
1784 |
3.633e-18 |
5.829e-16 |
30 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
124 |
823 |
4.925e-18 |
7.639e-16 |
31 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
110 |
689 |
6.02e-18 |
9.036e-16 |
32 |
REGULATION OF CELL PROLIFERATION |
187 |
1496 |
1.041e-17 |
1.514e-15 |
33 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
206 |
1710 |
1.096e-17 |
1.545e-15 |
34 |
PROTEIN PHOSPHORYLATION |
134 |
944 |
3.314e-17 |
4.535e-15 |
35 |
EPITHELIUM DEVELOPMENT |
134 |
945 |
3.621e-17 |
4.814e-15 |
36 |
MUSCLE STRUCTURE DEVELOPMENT |
79 |
432 |
1.594e-16 |
2.061e-14 |
37 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
141 |
1036 |
1.735e-16 |
2.125e-14 |
38 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
141 |
1036 |
1.735e-16 |
2.125e-14 |
39 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
214 |
1848 |
1.968e-16 |
2.347e-14 |
40 |
TISSUE MORPHOGENESIS |
90 |
533 |
2.145e-16 |
2.435e-14 |
41 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
76 |
408 |
2.125e-16 |
2.435e-14 |
42 |
POSITIVE REGULATION OF CELL COMMUNICATION |
186 |
1532 |
2.572e-16 |
2.85e-14 |
43 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
124 |
872 |
4.865e-16 |
5.264e-14 |
44 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
87 |
513 |
5.297e-16 |
5.601e-14 |
45 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
208 |
1805 |
9.633e-16 |
9.961e-14 |
46 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
78 |
437 |
1.012e-15 |
1.024e-13 |
47 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
135 |
1004 |
2.166e-15 |
2.145e-13 |
48 |
HEAD DEVELOPMENT |
106 |
709 |
2.585e-15 |
2.506e-13 |
49 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
81 |
472 |
2.819e-15 |
2.677e-13 |
50 |
CELLULAR COMPONENT MORPHOGENESIS |
124 |
900 |
5.433e-15 |
5.056e-13 |
51 |
TUBE DEVELOPMENT |
89 |
552 |
5.589e-15 |
5.099e-13 |
52 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
114 |
799 |
6.379e-15 |
5.662e-13 |
53 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
204 |
1791 |
6.449e-15 |
5.662e-13 |
54 |
CELL MOTILITY |
117 |
835 |
1.016e-14 |
8.598e-13 |
55 |
LOCALIZATION OF CELL |
117 |
835 |
1.016e-14 |
8.598e-13 |
56 |
REGULATION OF CELL PROJECTION ORGANIZATION |
89 |
558 |
1.078e-14 |
8.961e-13 |
57 |
REGULATION OF CELL MORPHOGENESIS |
88 |
552 |
1.577e-14 |
1.287e-12 |
58 |
SKELETAL SYSTEM DEVELOPMENT |
77 |
455 |
3.003e-14 |
2.409e-12 |
59 |
TUBE MORPHOGENESIS |
62 |
323 |
3.158e-14 |
2.49e-12 |
60 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
166 |
1381 |
3.236e-14 |
2.509e-12 |
61 |
EMBRYO DEVELOPMENT |
121 |
894 |
4.352e-14 |
3.266e-12 |
62 |
HEART MORPHOGENESIS |
48 |
212 |
4.325e-14 |
3.266e-12 |
63 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
112 |
801 |
4.546e-14 |
3.358e-12 |
64 |
NEURON PROJECTION DEVELOPMENT |
86 |
545 |
5.757e-14 |
4.185e-12 |
65 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
216 |
1977 |
7.236e-14 |
5.18e-12 |
66 |
EMBRYONIC MORPHOGENESIS |
85 |
539 |
8.403e-14 |
5.924e-12 |
67 |
NEURON DEVELOPMENT |
100 |
687 |
9.225e-14 |
6.406e-12 |
68 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
59 |
306 |
1.086e-13 |
7.43e-12 |
69 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
128 |
983 |
1.363e-13 |
9.191e-12 |
70 |
MUSCLE TISSUE DEVELOPMENT |
55 |
275 |
1.558e-13 |
1.036e-11 |
71 |
REGULATION OF SYSTEM PROCESS |
81 |
507 |
1.613e-13 |
1.057e-11 |
72 |
POSITIVE REGULATION OF GENE EXPRESSION |
194 |
1733 |
1.804e-13 |
1.166e-11 |
73 |
POSITIVE REGULATION OF CELL PROLIFERATION |
111 |
814 |
3.211e-13 |
2.047e-11 |
74 |
REGULATION OF GTPASE ACTIVITY |
97 |
673 |
4.045e-13 |
2.544e-11 |
75 |
BEHAVIOR |
81 |
516 |
4.227e-13 |
2.622e-11 |
76 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
209 |
1929 |
4.612e-13 |
2.824e-11 |
77 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
79 |
498 |
4.746e-13 |
2.868e-11 |
78 |
MUSCLE ORGAN DEVELOPMENT |
54 |
277 |
7.632e-13 |
4.495e-11 |
79 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
61 |
337 |
7.588e-13 |
4.495e-11 |
80 |
PHOSPHORYLATION |
148 |
1228 |
7.75e-13 |
4.508e-11 |
81 |
MORPHOGENESIS OF AN EPITHELIUM |
68 |
400 |
7.949e-13 |
4.566e-11 |
82 |
MESENCHYME DEVELOPMENT |
43 |
190 |
9.257e-13 |
5.253e-11 |
83 |
REGULATION OF CELL DEATH |
169 |
1472 |
1.019e-12 |
5.71e-11 |
84 |
SINGLE ORGANISM BEHAVIOR |
66 |
384 |
1.036e-12 |
5.737e-11 |
85 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
70 |
422 |
1.221e-12 |
6.683e-11 |
86 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
139 |
1135 |
1.269e-12 |
6.868e-11 |
87 |
REGULATION OF DEVELOPMENTAL GROWTH |
55 |
289 |
1.294e-12 |
6.919e-11 |
88 |
DEVELOPMENTAL GROWTH |
60 |
333 |
1.436e-12 |
7.595e-11 |
89 |
REGULATION OF MAPK CASCADE |
94 |
660 |
1.91e-12 |
9.987e-11 |
90 |
GROWTH |
68 |
410 |
2.593e-12 |
1.34e-10 |
91 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
47 |
229 |
3.5e-12 |
1.79e-10 |
92 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
88 |
609 |
4.522e-12 |
2.287e-10 |
93 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
81 |
541 |
5.281e-12 |
2.614e-10 |
94 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
81 |
541 |
5.281e-12 |
2.614e-10 |
95 |
ANGIOGENESIS |
54 |
293 |
7.681e-12 |
3.762e-10 |
96 |
ACTIN FILAMENT BASED PROCESS |
71 |
450 |
9.61e-12 |
4.658e-10 |
97 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
167 |
1492 |
1.153e-11 |
5.529e-10 |
98 |
CARDIAC CHAMBER DEVELOPMENT |
35 |
144 |
1.413e-11 |
6.71e-10 |
99 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
90 |
643 |
1.511e-11 |
7.102e-10 |
100 |
RESPONSE TO GROWTH FACTOR |
73 |
475 |
1.751e-11 |
8.147e-10 |
101 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
99 |
740 |
2.016e-11 |
9.29e-10 |
102 |
RESPONSE TO HORMONE |
113 |
893 |
2.543e-11 |
1.16e-09 |
103 |
FOREBRAIN DEVELOPMENT |
60 |
357 |
2.916e-11 |
1.317e-09 |
104 |
REGULATION OF HYDROLASE ACTIVITY |
151 |
1327 |
3.773e-11 |
1.688e-09 |
105 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
139 |
1192 |
4.497e-11 |
1.993e-09 |
106 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
167 |
1518 |
4.602e-11 |
2.02e-09 |
107 |
POSITIVE REGULATION OF LOCOMOTION |
66 |
420 |
6.245e-11 |
2.716e-09 |
108 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
153 |
1360 |
6.482e-11 |
2.793e-09 |
109 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
110 |
876 |
7.588e-11 |
3.239e-09 |
110 |
REGULATION OF TRANSPORT |
190 |
1804 |
7.698e-11 |
3.256e-09 |
111 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
33 |
138 |
8.591e-11 |
3.601e-09 |
112 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
79 |
552 |
9.337e-11 |
3.879e-09 |
113 |
CELL PROJECTION ORGANIZATION |
112 |
902 |
1.004e-10 |
4.132e-09 |
114 |
SENSORY ORGAN DEVELOPMENT |
73 |
493 |
1.022e-10 |
4.17e-09 |
115 |
CONNECTIVE TISSUE DEVELOPMENT |
40 |
194 |
1.222e-10 |
4.946e-09 |
116 |
CELL CELL ADHESION |
84 |
608 |
1.433e-10 |
5.747e-09 |
117 |
REGULATION OF CELL ADHESION |
86 |
629 |
1.471e-10 |
5.848e-09 |
118 |
UROGENITAL SYSTEM DEVELOPMENT |
52 |
299 |
1.72e-10 |
6.781e-09 |
119 |
NEURON PROJECTION MORPHOGENESIS |
63 |
402 |
1.914e-10 |
7.483e-09 |
120 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
44 |
232 |
2.568e-10 |
9.958e-09 |
121 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
36 |
167 |
2.801e-10 |
1.077e-08 |
122 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
52 |
303 |
2.823e-10 |
1.077e-08 |
123 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
66 |
437 |
3.518e-10 |
1.331e-08 |
124 |
MUSCLE CELL DIFFERENTIATION |
44 |
237 |
5.222e-10 |
1.96e-08 |
125 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
32 |
140 |
5.694e-10 |
2.12e-08 |
126 |
CARDIAC CHAMBER MORPHOGENESIS |
27 |
104 |
6.16e-10 |
2.275e-08 |
127 |
REGULATION OF KINASE ACTIVITY |
98 |
776 |
6.382e-10 |
2.32e-08 |
128 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
83 |
616 |
6.381e-10 |
2.32e-08 |
129 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
77 |
554 |
6.467e-10 |
2.333e-08 |
130 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
97 |
767 |
7.266e-10 |
2.601e-08 |
131 |
MESENCHYMAL CELL DIFFERENTIATION |
31 |
134 |
7.681e-10 |
2.728e-08 |
132 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
58 |
368 |
8.097e-10 |
2.854e-08 |
133 |
CARDIAC SEPTUM DEVELOPMENT |
24 |
85 |
8.589e-10 |
3.005e-08 |
134 |
REGULATION OF EPITHELIAL CELL MIGRATION |
35 |
166 |
9.298e-10 |
3.229e-08 |
135 |
CYTOSKELETON ORGANIZATION |
103 |
838 |
1.043e-09 |
3.595e-08 |
136 |
NEGATIVE REGULATION OF CELL DEATH |
106 |
872 |
1.098e-09 |
3.757e-08 |
137 |
POSITIVE REGULATION OF MAPK CASCADE |
68 |
470 |
1.223e-09 |
4.153e-08 |
138 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
19 |
56 |
1.602e-09 |
5.402e-08 |
139 |
REGULATION OF TRANSFERASE ACTIVITY |
112 |
946 |
1.685e-09 |
5.601e-08 |
140 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
130 |
1152 |
1.685e-09 |
5.601e-08 |
141 |
REGULATION OF OSSIFICATION |
36 |
178 |
1.781e-09 |
5.878e-08 |
142 |
RESPONSE TO OXYGEN LEVELS |
51 |
311 |
2.136e-09 |
7e-08 |
143 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
108 |
905 |
2.153e-09 |
7.007e-08 |
144 |
NEURON MIGRATION |
27 |
110 |
2.368e-09 |
7.65e-08 |
145 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
33 |
156 |
2.555e-09 |
8.2e-08 |
146 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
50 |
304 |
2.769e-09 |
8.826e-08 |
147 |
REGULATION OF BLOOD CIRCULATION |
49 |
295 |
2.849e-09 |
9.019e-08 |
148 |
REGULATION OF CELL SUBSTRATE ADHESION |
35 |
173 |
2.958e-09 |
9.301e-08 |
149 |
COGNITION |
44 |
251 |
3.366e-09 |
1.051e-07 |
150 |
POSITIVE REGULATION OF HEART GROWTH |
13 |
27 |
4.091e-09 |
1.269e-07 |
151 |
TAXIS |
66 |
464 |
4.317e-09 |
1.33e-07 |
152 |
VASCULOGENESIS |
19 |
59 |
4.348e-09 |
1.331e-07 |
153 |
EPITHELIAL CELL DIFFERENTIATION |
69 |
495 |
4.497e-09 |
1.368e-07 |
154 |
SKELETAL SYSTEM MORPHOGENESIS |
38 |
201 |
4.631e-09 |
1.399e-07 |
155 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
11 |
19 |
5.168e-09 |
1.551e-07 |
156 |
MUSCLE SYSTEM PROCESS |
47 |
282 |
5.349e-09 |
1.585e-07 |
157 |
TELENCEPHALON DEVELOPMENT |
41 |
228 |
5.343e-09 |
1.585e-07 |
158 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
49 |
303 |
7.051e-09 |
2.077e-07 |
159 |
POSITIVE REGULATION OF ORGAN GROWTH |
15 |
38 |
7.717e-09 |
2.258e-07 |
160 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
158 |
1517 |
8.325e-09 |
2.421e-07 |
161 |
INOSITOL LIPID MEDIATED SIGNALING |
28 |
124 |
8.936e-09 |
2.583e-07 |
162 |
BONE DEVELOPMENT |
32 |
156 |
9.804e-09 |
2.799e-07 |
163 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
46 |
278 |
9.793e-09 |
2.799e-07 |
164 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
25 |
103 |
1.175e-08 |
3.333e-07 |
165 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
44 |
262 |
1.295e-08 |
3.651e-07 |
166 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
25 |
104 |
1.45e-08 |
4.064e-07 |
167 |
RESPONSE TO WOUNDING |
74 |
563 |
1.603e-08 |
4.466e-07 |
168 |
RESPONSE TO ABIOTIC STIMULUS |
115 |
1024 |
2.056e-08 |
5.695e-07 |
169 |
REGULATION OF HEART CONTRACTION |
39 |
221 |
2.148e-08 |
5.9e-07 |
170 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
46 |
285 |
2.156e-08 |
5.9e-07 |
171 |
REGULATION OF MEMBRANE POTENTIAL |
52 |
343 |
2.307e-08 |
6.278e-07 |
172 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
68 |
505 |
2.372e-08 |
6.416e-07 |
173 |
REGULATION OF GROWTH |
80 |
633 |
2.427e-08 |
6.529e-07 |
174 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
88 |
724 |
3.035e-08 |
8.116e-07 |
175 |
RESPONSE TO NITROGEN COMPOUND |
100 |
859 |
3.095e-08 |
8.23e-07 |
176 |
BONE MORPHOGENESIS |
21 |
79 |
3.115e-08 |
8.235e-07 |
177 |
CELLULAR RESPONSE TO LIPID |
63 |
457 |
3.231e-08 |
8.493e-07 |
178 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
105 |
917 |
3.264e-08 |
8.531e-07 |
179 |
STEM CELL DIFFERENTIATION |
35 |
190 |
3.699e-08 |
9.615e-07 |
180 |
REGULATION OF ORGAN GROWTH |
20 |
73 |
3.795e-08 |
9.809e-07 |
181 |
NEGATIVE REGULATION OF GENE EXPRESSION |
153 |
1493 |
4.264e-08 |
1.096e-06 |
182 |
KIDNEY EPITHELIUM DEVELOPMENT |
27 |
125 |
4.439e-08 |
1.129e-06 |
183 |
RESPONSE TO LIPID |
102 |
888 |
4.42e-08 |
1.129e-06 |
184 |
POSITIVE REGULATION OF KINASE ACTIVITY |
65 |
482 |
4.57e-08 |
1.156e-06 |
185 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
24 |
103 |
5.346e-08 |
1.345e-06 |
186 |
CARDIOCYTE DIFFERENTIATION |
23 |
96 |
5.811e-08 |
1.446e-06 |
187 |
CARDIAC SEPTUM MORPHOGENESIS |
16 |
49 |
5.799e-08 |
1.446e-06 |
188 |
REGULATION OF CELL JUNCTION ASSEMBLY |
19 |
68 |
5.853e-08 |
1.449e-06 |
189 |
REGULATION OF AXONOGENESIS |
32 |
168 |
6.25e-08 |
1.539e-06 |
190 |
CARDIAC VENTRICLE MORPHOGENESIS |
18 |
62 |
6.802e-08 |
1.657e-06 |
191 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
18 |
62 |
6.802e-08 |
1.657e-06 |
192 |
APPENDAGE DEVELOPMENT |
32 |
169 |
7.224e-08 |
1.742e-06 |
193 |
LIMB DEVELOPMENT |
32 |
169 |
7.224e-08 |
1.742e-06 |
194 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
29 |
144 |
7.295e-08 |
1.75e-06 |
195 |
OUTFLOW TRACT MORPHOGENESIS |
17 |
56 |
7.583e-08 |
1.809e-06 |
196 |
REGULATION OF CELL MATRIX ADHESION |
22 |
90 |
7.639e-08 |
1.813e-06 |
197 |
EMBRYONIC ORGAN DEVELOPMENT |
57 |
406 |
7.76e-08 |
1.833e-06 |
198 |
CIRCULATORY SYSTEM PROCESS |
53 |
366 |
8.003e-08 |
1.881e-06 |
199 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
118 |
1087 |
8.692e-08 |
2.032e-06 |
200 |
SINGLE ORGANISM CELL ADHESION |
62 |
459 |
8.797e-08 |
2.047e-06 |
201 |
REGULATION OF VASCULATURE DEVELOPMENT |
39 |
233 |
9.383e-08 |
2.172e-06 |
202 |
RESPIRATORY SYSTEM DEVELOPMENT |
35 |
197 |
9.439e-08 |
2.174e-06 |
203 |
CARDIAC VENTRICLE DEVELOPMENT |
24 |
106 |
9.594e-08 |
2.199e-06 |
204 |
LIPID PHOSPHORYLATION |
23 |
99 |
1.068e-07 |
2.437e-06 |
205 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
27 |
131 |
1.239e-07 |
2.813e-06 |
206 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
12 |
29 |
1.332e-07 |
2.993e-06 |
207 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
12 |
29 |
1.332e-07 |
2.993e-06 |
208 |
IMMUNE SYSTEM DEVELOPMENT |
73 |
582 |
1.357e-07 |
3.032e-06 |
209 |
CELL FATE COMMITMENT |
38 |
227 |
1.362e-07 |
3.032e-06 |
210 |
REGULATION OF EXTENT OF CELL GROWTH |
23 |
101 |
1.579e-07 |
3.499e-06 |
211 |
PATTERN SPECIFICATION PROCESS |
57 |
418 |
2.109e-07 |
4.65e-06 |
212 |
RHYTHMIC PROCESS |
45 |
298 |
2.256e-07 |
4.952e-06 |
213 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
38 |
232 |
2.425e-07 |
5.297e-06 |
214 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
18 |
67 |
2.502e-07 |
5.44e-06 |
215 |
REGULATION OF ION TRANSPORT |
73 |
592 |
2.659e-07 |
5.755e-06 |
216 |
REGULATION OF HEART GROWTH |
14 |
42 |
2.926e-07 |
6.303e-06 |
217 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
75 |
616 |
3.026e-07 |
6.488e-06 |
218 |
NEURAL CREST CELL DIFFERENTIATION |
19 |
75 |
3.198e-07 |
6.826e-06 |
219 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
115 |
1079 |
3.321e-07 |
7.056e-06 |
220 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
16 |
55 |
3.517e-07 |
7.372e-06 |
221 |
REGULATION OF BINDING |
43 |
283 |
3.502e-07 |
7.372e-06 |
222 |
MESONEPHROS DEVELOPMENT |
21 |
90 |
3.502e-07 |
7.372e-06 |
223 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
24 |
114 |
4.063e-07 |
8.478e-06 |
224 |
CARTILAGE DEVELOPMENT |
28 |
147 |
4.101e-07 |
8.518e-06 |
225 |
STRIATED MUSCLE CELL DIFFERENTIATION |
31 |
173 |
4.14e-07 |
8.561e-06 |
226 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
33 |
191 |
4.247e-07 |
8.745e-06 |
227 |
CELL PART MORPHOGENESIS |
76 |
633 |
4.398e-07 |
9.015e-06 |
228 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
61 |
470 |
4.559e-07 |
9.305e-06 |
229 |
POSITIVE REGULATION OF GROWTH |
38 |
238 |
4.715e-07 |
9.579e-06 |
230 |
REGULATION OF BMP SIGNALING PATHWAY |
19 |
77 |
4.98e-07 |
1.008e-05 |
231 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
15 |
50 |
5.242e-07 |
1.056e-05 |
232 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
32 |
184 |
5.437e-07 |
1.09e-05 |
233 |
PALATE DEVELOPMENT |
20 |
85 |
5.736e-07 |
1.145e-05 |
234 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
16 |
57 |
6.028e-07 |
1.199e-05 |
235 |
POSITIVE REGULATION OF CELL DEATH |
73 |
605 |
6.152e-07 |
1.218e-05 |
236 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
26 |
133 |
6.247e-07 |
1.232e-05 |
237 |
ACTIN FILAMENT BASED MOVEMENT |
21 |
93 |
6.283e-07 |
1.234e-05 |
238 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
34 |
204 |
6.797e-07 |
1.329e-05 |
239 |
EAR DEVELOPMENT |
33 |
195 |
6.919e-07 |
1.341e-05 |
240 |
REGULATION OF MUSCLE SYSTEM PROCESS |
33 |
195 |
6.919e-07 |
1.341e-05 |
241 |
PEPTIDYL TYROSINE MODIFICATION |
32 |
186 |
6.972e-07 |
1.346e-05 |
242 |
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT |
14 |
45 |
7.643e-07 |
1.464e-05 |
243 |
NEURON PROJECTION GUIDANCE |
34 |
205 |
7.635e-07 |
1.464e-05 |
244 |
REGIONALIZATION |
45 |
311 |
7.693e-07 |
1.467e-05 |
245 |
NEGATIVE REGULATION OF LOCOMOTION |
40 |
263 |
8.665e-07 |
1.646e-05 |
246 |
REGULATION OF HOMEOSTATIC PROCESS |
58 |
447 |
8.783e-07 |
1.661e-05 |
247 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
27 |
144 |
9.078e-07 |
1.71e-05 |
248 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
22 |
103 |
9.432e-07 |
1.77e-05 |
249 |
PALLIUM DEVELOPMENT |
28 |
153 |
9.562e-07 |
1.787e-05 |
250 |
CELL ACTIVATION |
69 |
568 |
9.784e-07 |
1.821e-05 |
251 |
REGULATION OF TRANSPORTER ACTIVITY |
33 |
198 |
9.868e-07 |
1.829e-05 |
252 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
12 |
34 |
1.029e-06 |
1.892e-05 |
253 |
CAMP METABOLIC PROCESS |
12 |
34 |
1.029e-06 |
1.892e-05 |
254 |
SYNAPSE ORGANIZATION |
27 |
145 |
1.046e-06 |
1.915e-05 |
255 |
AMEBOIDAL TYPE CELL MIGRATION |
28 |
154 |
1.095e-06 |
1.999e-05 |
256 |
PROTEIN DEPHOSPHORYLATION |
32 |
190 |
1.132e-06 |
2.057e-05 |
257 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
60 |
472 |
1.137e-06 |
2.058e-05 |
258 |
EYE DEVELOPMENT |
46 |
326 |
1.191e-06 |
2.149e-05 |
259 |
REGULATION OF SYNAPSE ORGANIZATION |
23 |
113 |
1.315e-06 |
2.362e-05 |
260 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
59 |
465 |
1.482e-06 |
2.652e-05 |
261 |
ENDOTHELIUM DEVELOPMENT |
20 |
90 |
1.512e-06 |
2.695e-05 |
262 |
ARTERY DEVELOPMENT |
18 |
75 |
1.532e-06 |
2.721e-05 |
263 |
ORGAN GROWTH |
17 |
68 |
1.619e-06 |
2.863e-05 |
264 |
CELLULAR RESPONSE TO ACID CHEMICAL |
30 |
175 |
1.66e-06 |
2.926e-05 |
265 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
32 |
194 |
1.806e-06 |
3.16e-05 |
266 |
POSITIVE REGULATION OF TRANSPORT |
100 |
936 |
1.805e-06 |
3.16e-05 |
267 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
53 |
404 |
1.85e-06 |
3.224e-05 |
268 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
44 |
312 |
2.051e-06 |
3.56e-05 |
269 |
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
12 |
36 |
2.073e-06 |
3.572e-05 |
270 |
MUSCLE CONTRACTION |
36 |
233 |
2.07e-06 |
3.572e-05 |
271 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
18 |
77 |
2.307e-06 |
3.96e-05 |
272 |
SECOND MESSENGER MEDIATED SIGNALING |
28 |
160 |
2.405e-06 |
4.098e-05 |
273 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
14 |
49 |
2.403e-06 |
4.098e-05 |
274 |
REGULATION OF METAL ION TRANSPORT |
45 |
325 |
2.603e-06 |
4.421e-05 |
275 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
26 |
143 |
2.621e-06 |
4.435e-05 |
276 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
33 |
207 |
2.715e-06 |
4.578e-05 |
277 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
8 |
16 |
3.062e-06 |
5.143e-05 |
278 |
RHO PROTEIN SIGNAL TRANSDUCTION |
14 |
50 |
3.134e-06 |
5.246e-05 |
279 |
HEART TRABECULA MORPHOGENESIS |
10 |
26 |
3.357e-06 |
5.598e-05 |
280 |
LOCOMOTORY BEHAVIOR |
30 |
181 |
3.395e-06 |
5.642e-05 |
281 |
MUSCLE CELL DEVELOPMENT |
24 |
128 |
3.603e-06 |
5.967e-05 |
282 |
REGULATION OF MAP KINASE ACTIVITY |
44 |
319 |
3.71e-06 |
6.122e-05 |
283 |
ENDOTHELIAL CELL DIFFERENTIATION |
17 |
72 |
3.785e-06 |
6.223e-05 |
284 |
REGULATION OF DENDRITE DEVELOPMENT |
23 |
120 |
3.88e-06 |
6.356e-05 |
285 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
33 |
211 |
4.157e-06 |
6.787e-05 |
286 |
IN UTERO EMBRYONIC DEVELOPMENT |
43 |
311 |
4.478e-06 |
7.285e-05 |
287 |
MODULATION OF SYNAPTIC TRANSMISSION |
42 |
301 |
4.563e-06 |
7.399e-05 |
288 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
31 |
193 |
4.598e-06 |
7.429e-05 |
289 |
CELL CELL SIGNALING |
84 |
767 |
4.778e-06 |
7.693e-05 |
290 |
CHEMICAL HOMEOSTASIS |
93 |
874 |
4.939e-06 |
7.897e-05 |
291 |
RESPONSE TO EXTERNAL STIMULUS |
169 |
1821 |
4.925e-06 |
7.897e-05 |
292 |
METANEPHROS DEVELOPMENT |
18 |
81 |
4.992e-06 |
7.955e-05 |
293 |
SEGMENTATION |
19 |
89 |
5.159e-06 |
8.192e-05 |
294 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
12 |
39 |
5.37e-06 |
8.47e-05 |
295 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
12 |
39 |
5.37e-06 |
8.47e-05 |
296 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
17 |
74 |
5.641e-06 |
8.838e-05 |
297 |
ACTIN MEDIATED CELL CONTRACTION |
17 |
74 |
5.641e-06 |
8.838e-05 |
298 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
14 |
53 |
6.651e-06 |
0.0001038 |
299 |
REGULATION OF FATTY ACID OXIDATION |
10 |
28 |
7.332e-06 |
0.0001141 |
300 |
LEUKOCYTE ACTIVATION |
52 |
414 |
8.19e-06 |
0.000127 |
301 |
CARDIAC MUSCLE TISSUE MORPHOGENESIS |
14 |
54 |
8.431e-06 |
0.0001295 |
302 |
VENTRICULAR SEPTUM DEVELOPMENT |
14 |
54 |
8.431e-06 |
0.0001295 |
303 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
20 |
100 |
8.379e-06 |
0.0001295 |
304 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
22 |
117 |
8.632e-06 |
0.0001321 |
305 |
REGULATION OF ERK1 AND ERK2 CASCADE |
35 |
238 |
8.789e-06 |
0.0001341 |
306 |
PERICARDIUM DEVELOPMENT |
8 |
18 |
9.225e-06 |
0.0001403 |
307 |
NEGATIVE REGULATION OF OSSIFICATION |
16 |
69 |
9.303e-06 |
0.000141 |
308 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
26 |
153 |
9.429e-06 |
0.0001424 |
309 |
EMBRYONIC ORGAN MORPHOGENESIS |
39 |
279 |
9.463e-06 |
0.0001425 |
310 |
AORTA DEVELOPMENT |
12 |
41 |
9.575e-06 |
0.0001437 |
311 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
46 |
352 |
9.64e-06 |
0.0001442 |
312 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
22 |
118 |
9.951e-06 |
0.0001484 |
313 |
LIPID MODIFICATION |
32 |
210 |
1.004e-05 |
0.0001493 |
314 |
REGULATION OF CELL SIZE |
28 |
172 |
1.009e-05 |
0.0001496 |
315 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
13 |
48 |
1.051e-05 |
0.0001549 |
316 |
CARDIAC MUSCLE CELL CONTRACTION |
10 |
29 |
1.052e-05 |
0.0001549 |
317 |
MUSCLE ORGAN MORPHOGENESIS |
16 |
70 |
1.132e-05 |
0.0001661 |
318 |
REGULATION OF NEURON APOPTOTIC PROCESS |
30 |
192 |
1.141e-05 |
0.0001669 |
319 |
LEUKOCYTE DIFFERENTIATION |
40 |
292 |
1.191e-05 |
0.0001737 |
320 |
SOMITE DEVELOPMENT |
17 |
78 |
1.196e-05 |
0.0001739 |
321 |
RESPONSE TO STEROID HORMONE |
59 |
497 |
1.2e-05 |
0.000174 |
322 |
REGULATION OF LIPID METABOLIC PROCESS |
39 |
282 |
1.219e-05 |
0.0001761 |
323 |
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS |
12 |
42 |
1.259e-05 |
0.0001798 |
324 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
12 |
42 |
1.259e-05 |
0.0001798 |
325 |
REGULATION OF MUSCLE ADAPTATION |
15 |
63 |
1.25e-05 |
0.0001798 |
326 |
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS |
12 |
42 |
1.259e-05 |
0.0001798 |
327 |
REGULATION OF NEURON DEATH |
36 |
252 |
1.269e-05 |
0.0001804 |
328 |
REGULATION OF ORGAN MORPHOGENESIS |
35 |
242 |
1.272e-05 |
0.0001804 |
329 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
7 |
14 |
1.315e-05 |
0.0001859 |
330 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
14 |
56 |
1.33e-05 |
0.0001875 |
331 |
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
9 |
24 |
1.338e-05 |
0.0001881 |
332 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
21 |
112 |
1.436e-05 |
0.0002013 |
333 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
10 |
30 |
1.484e-05 |
0.0002062 |
334 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
10 |
30 |
1.484e-05 |
0.0002062 |
335 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
10 |
30 |
1.484e-05 |
0.0002062 |
336 |
RESPONSE TO INORGANIC SUBSTANCE |
57 |
479 |
1.565e-05 |
0.0002167 |
337 |
REGULATION OF RESPONSE TO WOUNDING |
51 |
413 |
1.596e-05 |
0.0002204 |
338 |
CELLULAR CHEMICAL HOMEOSTASIS |
65 |
570 |
1.616e-05 |
0.0002225 |
339 |
REGULATION OF CELL CYCLE |
97 |
949 |
1.635e-05 |
0.0002244 |
340 |
REGULATION OF STEM CELL DIFFERENTIATION |
21 |
113 |
1.655e-05 |
0.0002264 |
341 |
REGULATION OF COENZYME METABOLIC PROCESS |
13 |
50 |
1.705e-05 |
0.000232 |
342 |
REGULATION OF COFACTOR METABOLIC PROCESS |
13 |
50 |
1.705e-05 |
0.000232 |
343 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
23 |
131 |
1.76e-05 |
0.0002387 |
344 |
REGULATION OF CYTOPLASMIC TRANSPORT |
57 |
481 |
1.768e-05 |
0.0002391 |
345 |
WOUND HEALING |
56 |
470 |
1.786e-05 |
0.0002409 |
346 |
CEREBRAL CORTEX DEVELOPMENT |
20 |
105 |
1.792e-05 |
0.000241 |
347 |
SYSTEM PROCESS |
163 |
1785 |
1.821e-05 |
0.0002441 |
348 |
CELL DEATH |
101 |
1001 |
1.864e-05 |
0.0002492 |
349 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
11 |
37 |
1.909e-05 |
0.0002546 |
350 |
RESPONSE TO ALCOHOL |
46 |
362 |
1.991e-05 |
0.0002647 |
351 |
EMBRYONIC PATTERN SPECIFICATION |
14 |
58 |
2.049e-05 |
0.0002716 |
352 |
CARDIAC ATRIUM DEVELOPMENT |
10 |
31 |
2.06e-05 |
0.0002724 |
353 |
NEURAL CREST CELL MIGRATION |
13 |
51 |
2.15e-05 |
0.0002825 |
354 |
ARTERY MORPHOGENESIS |
13 |
51 |
2.15e-05 |
0.0002825 |
355 |
LYMPHOCYTE ACTIVATION |
44 |
342 |
2.206e-05 |
0.0002892 |
356 |
MEMORY |
19 |
98 |
2.221e-05 |
0.0002903 |
357 |
SECRETION |
66 |
588 |
2.305e-05 |
0.0003005 |
358 |
CALCIUM MEDIATED SIGNALING |
18 |
90 |
2.336e-05 |
0.0003036 |
359 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
8 |
20 |
2.354e-05 |
0.0003051 |
360 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
50 |
408 |
2.362e-05 |
0.0003053 |
361 |
NEGATIVE REGULATION OF NEURON DEATH |
27 |
171 |
2.538e-05 |
0.0003271 |
362 |
CELL PROLIFERATION |
73 |
672 |
2.618e-05 |
0.0003366 |
363 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
26 |
162 |
2.664e-05 |
0.0003414 |
364 |
POSITIVE REGULATION OF BMP SIGNALING PATHWAY |
10 |
32 |
2.818e-05 |
0.0003593 |
365 |
ADIPOSE TISSUE DEVELOPMENT |
10 |
32 |
2.818e-05 |
0.0003593 |
366 |
CELL GROWTH |
23 |
135 |
2.9e-05 |
0.0003683 |
367 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
22 |
126 |
2.905e-05 |
0.0003683 |
368 |
CARDIAC MUSCLE ADAPTATION |
6 |
11 |
3.018e-05 |
0.0003775 |
369 |
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
6 |
11 |
3.018e-05 |
0.0003775 |
370 |
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS |
6 |
11 |
3.018e-05 |
0.0003775 |
371 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
19 |
100 |
2.988e-05 |
0.0003775 |
372 |
CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
6 |
11 |
3.018e-05 |
0.0003775 |
373 |
PROTEIN AUTOPHOSPHORYLATION |
29 |
192 |
3.041e-05 |
0.0003793 |
374 |
REGULATION OF GLUCOSE IMPORT |
14 |
60 |
3.091e-05 |
0.0003835 |
375 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
14 |
60 |
3.091e-05 |
0.0003835 |
376 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
25 |
154 |
3.102e-05 |
0.0003839 |
377 |
REGULATION OF CELLULAR LOCALIZATION |
122 |
1277 |
3.218e-05 |
0.0003972 |
378 |
REGULATION OF CELL GROWTH |
48 |
391 |
3.265e-05 |
0.0004019 |
379 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
11 |
39 |
3.308e-05 |
0.000405 |
380 |
TRABECULA MORPHOGENESIS |
11 |
39 |
3.308e-05 |
0.000405 |
381 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
17 |
84 |
3.329e-05 |
0.0004066 |
382 |
CELLULAR RESPONSE TO PEPTIDE |
37 |
274 |
3.421e-05 |
0.0004166 |
383 |
MULTI MULTICELLULAR ORGANISM PROCESS |
31 |
213 |
3.443e-05 |
0.0004183 |
384 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
8 |
21 |
3.58e-05 |
0.0004338 |
385 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
51 |
426 |
3.677e-05 |
0.0004444 |
386 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
23 |
137 |
3.689e-05 |
0.0004447 |
387 |
MEMBRANE DEPOLARIZATION |
14 |
61 |
3.767e-05 |
0.000453 |
388 |
NEGATIVE REGULATION OF JNK CASCADE |
10 |
33 |
3.803e-05 |
0.0004549 |
389 |
EMBRYONIC EYE MORPHOGENESIS |
10 |
33 |
3.803e-05 |
0.0004549 |
390 |
HIPPO SIGNALING |
9 |
27 |
3.995e-05 |
0.0004762 |
391 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
39 |
297 |
4.012e-05 |
0.0004762 |
392 |
DEVELOPMENTAL CELL GROWTH |
16 |
77 |
4.007e-05 |
0.0004762 |
393 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
26 |
166 |
4.097e-05 |
0.0004851 |
394 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
20 |
111 |
4.15e-05 |
0.0004901 |
395 |
CELL JUNCTION ASSEMBLY |
22 |
129 |
4.221e-05 |
0.0004973 |
396 |
GLAND DEVELOPMENT |
48 |
395 |
4.232e-05 |
0.0004973 |
397 |
RESPONSE TO ACID CHEMICAL |
41 |
319 |
4.243e-05 |
0.0004974 |
398 |
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
11 |
40 |
4.289e-05 |
0.0005014 |
399 |
SOMITOGENESIS |
14 |
62 |
4.57e-05 |
0.000533 |
400 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
66 |
602 |
4.779e-05 |
0.0005559 |
401 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
21 |
121 |
4.796e-05 |
0.0005565 |
402 |
HORMONE MEDIATED SIGNALING PATHWAY |
25 |
158 |
4.812e-05 |
0.0005569 |
403 |
RESPONSE TO FLUID SHEAR STRESS |
10 |
34 |
5.067e-05 |
0.0005851 |
404 |
POSITIVE REGULATION OF CELL ADHESION |
46 |
376 |
5.143e-05 |
0.0005924 |
405 |
AORTA MORPHOGENESIS |
8 |
22 |
5.298e-05 |
0.0006086 |
406 |
LEARNING |
22 |
131 |
5.373e-05 |
0.0006158 |
407 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
11 |
41 |
5.51e-05 |
0.0006284 |
408 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
11 |
41 |
5.51e-05 |
0.0006284 |
409 |
VENTRICULAR SEPTUM MORPHOGENESIS |
9 |
28 |
5.539e-05 |
0.0006302 |
410 |
DENDRITE DEVELOPMENT |
16 |
79 |
5.572e-05 |
0.0006308 |
411 |
REGULATION OF SYNAPSE ASSEMBLY |
16 |
79 |
5.572e-05 |
0.0006308 |
412 |
CARTILAGE MORPHOGENESIS |
6 |
12 |
5.694e-05 |
0.0006431 |
413 |
SENSORY ORGAN MORPHOGENESIS |
33 |
239 |
5.719e-05 |
0.0006443 |
414 |
ODONTOGENESIS |
19 |
105 |
6.025e-05 |
0.0006772 |
415 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
34 |
250 |
6.057e-05 |
0.0006791 |
416 |
REGULATION OF STEM CELL PROLIFERATION |
17 |
88 |
6.201e-05 |
0.0006936 |
417 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
7 |
17 |
6.234e-05 |
0.0006956 |
418 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
28 |
190 |
6.466e-05 |
0.0007197 |
419 |
NEGATIVE REGULATION OF TRANSPORT |
53 |
458 |
6.506e-05 |
0.0007225 |
420 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
14 |
64 |
6.635e-05 |
0.0007351 |
421 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
12 |
49 |
6.799e-05 |
0.0007479 |
422 |
REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
12 |
49 |
6.799e-05 |
0.0007479 |
423 |
REGULATION OF ATP METABOLIC PROCESS |
12 |
49 |
6.799e-05 |
0.0007479 |
424 |
NEPHRON DEVELOPMENT |
20 |
115 |
6.982e-05 |
0.0007663 |
425 |
NEGATIVE REGULATION OF GTPASE ACTIVITY |
11 |
42 |
7.018e-05 |
0.0007684 |
426 |
REGULATION OF CELLULAR COMPONENT SIZE |
42 |
337 |
7.037e-05 |
0.0007686 |
427 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
17 |
89 |
7.195e-05 |
0.0007841 |
428 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
26 |
172 |
7.565e-05 |
0.0008205 |
429 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
26 |
172 |
7.565e-05 |
0.0008205 |
430 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
22 |
134 |
7.629e-05 |
0.0008255 |
431 |
STRIATED MUSCLE ADAPTATION |
8 |
23 |
7.649e-05 |
0.0008258 |
432 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
21 |
125 |
7.829e-05 |
0.0008433 |
433 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
15 |
73 |
7.928e-05 |
0.000852 |
434 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
12 |
50 |
8.408e-05 |
0.0008973 |
435 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
48 |
406 |
8.4e-05 |
0.0008973 |
436 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
12 |
50 |
8.408e-05 |
0.0008973 |
437 |
ADULT BEHAVIOR |
22 |
135 |
8.549e-05 |
0.0009103 |
438 |
DEPHOSPHORYLATION |
37 |
286 |
8.573e-05 |
0.0009107 |
439 |
SECRETION BY CELL |
55 |
486 |
8.705e-05 |
0.0009206 |
440 |
POSITIVE REGULATION OF AXON EXTENSION |
10 |
36 |
8.69e-05 |
0.0009206 |
441 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
11 |
43 |
8.867e-05 |
0.0009355 |
442 |
KIDNEY MORPHOGENESIS |
16 |
82 |
8.923e-05 |
0.0009394 |
443 |
CELL SUBSTRATE ADHESION |
25 |
164 |
8.978e-05 |
0.000943 |
444 |
LEUKOCYTE CELL CELL ADHESION |
34 |
255 |
9.016e-05 |
0.0009448 |
445 |
NEGATIVE REGULATION OF MAPK CASCADE |
23 |
145 |
9.137e-05 |
0.0009554 |
446 |
REGULATION OF DENDRITE MORPHOGENESIS |
15 |
74 |
9.338e-05 |
0.0009742 |
447 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
14 |
66 |
9.469e-05 |
0.0009857 |
448 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
7 |
18 |
9.614e-05 |
0.0009897 |
449 |
ATRIAL SEPTUM DEVELOPMENT |
7 |
18 |
9.614e-05 |
0.0009897 |
450 |
ENSHEATHMENT OF NEURONS |
17 |
91 |
9.612e-05 |
0.0009897 |
451 |
AXON ENSHEATHMENT |
17 |
91 |
9.612e-05 |
0.0009897 |
452 |
GLIAL CELL DIFFERENTIATION |
22 |
136 |
9.567e-05 |
0.0009897 |
453 |
RESPONSE TO DRUG |
50 |
431 |
9.732e-05 |
0.0009997 |
454 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE |
6 |
13 |
9.977e-05 |
0.00102 |
455 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
6 |
13 |
9.977e-05 |
0.00102 |
456 |
LIMBIC SYSTEM DEVELOPMENT |
18 |
100 |
0.0001002 |
0.001022 |
457 |
CELL JUNCTION ORGANIZATION |
27 |
185 |
0.0001024 |
0.001043 |
458 |
NEGATIVE REGULATION OF GROWTH |
32 |
236 |
0.0001042 |
0.001059 |
459 |
AXON REGENERATION |
8 |
24 |
0.000108 |
0.001091 |
460 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
8 |
24 |
0.000108 |
0.001091 |
461 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
8 |
24 |
0.000108 |
0.001091 |
462 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
11 |
44 |
0.0001112 |
0.001117 |
463 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
21 |
128 |
0.0001112 |
0.001117 |
464 |
AXON EXTENSION |
10 |
37 |
0.000112 |
0.001123 |
465 |
EPITHELIAL CELL DEVELOPMENT |
27 |
186 |
0.0001124 |
0.001124 |
466 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
16 |
84 |
0.0001204 |
0.001202 |
467 |
TUBE FORMATION |
21 |
129 |
0.0001246 |
0.001241 |
468 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
91 |
926 |
0.000125 |
0.001243 |
469 |
DIGESTIVE SYSTEM DEVELOPMENT |
23 |
148 |
0.0001256 |
0.001246 |
470 |
REGULATION OF DNA BINDING |
17 |
93 |
0.0001271 |
0.001259 |
471 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
30 |
218 |
0.0001294 |
0.001279 |
472 |
ION HOMEOSTASIS |
62 |
576 |
0.0001349 |
0.00133 |
473 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
11 |
45 |
0.0001383 |
0.001361 |
474 |
NEURAL TUBE DEVELOPMENT |
23 |
149 |
0.0001393 |
0.001368 |
475 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
7 |
19 |
0.0001435 |
0.0014 |
476 |
REGULATION OF CALCIUM ION TRANSPORT |
29 |
209 |
0.0001438 |
0.0014 |
477 |
REGULATION OF PEPTIDE SECRETION |
29 |
209 |
0.0001438 |
0.0014 |
478 |
LYMPHOCYTE DIFFERENTIATION |
29 |
209 |
0.0001438 |
0.0014 |
479 |
ACTION POTENTIAL |
17 |
94 |
0.0001457 |
0.001412 |
480 |
NEURAL TUBE FORMATION |
17 |
94 |
0.0001457 |
0.001412 |
481 |
MYELOID CELL DIFFERENTIATION |
27 |
189 |
0.0001475 |
0.001427 |
482 |
OSSIFICATION |
33 |
251 |
0.0001488 |
0.001436 |
483 |
HOMEOSTATIC PROCESS |
123 |
1337 |
0.0001527 |
0.001468 |
484 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
30 |
220 |
0.0001526 |
0.001468 |
485 |
POSITIVE REGULATION OF AXONOGENESIS |
14 |
69 |
0.0001567 |
0.001504 |
486 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
13 |
61 |
0.0001588 |
0.001517 |
487 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
13 |
61 |
0.0001588 |
0.001517 |
488 |
REGULATION OF HEART RATE |
16 |
86 |
0.0001606 |
0.001531 |
489 |
NEGATIVE REGULATION OF CELL GROWTH |
25 |
170 |
0.0001611 |
0.001533 |
490 |
REGULATION OF CHEMOTAXIS |
26 |
180 |
0.0001619 |
0.001537 |
491 |
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT |
6 |
14 |
0.0001647 |
0.001539 |
492 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
6 |
14 |
0.0001647 |
0.001539 |
493 |
NEGATIVE REGULATION OF JUN KINASE ACTIVITY |
6 |
14 |
0.0001647 |
0.001539 |
494 |
ATRIAL SEPTUM MORPHOGENESIS |
6 |
14 |
0.0001647 |
0.001539 |
495 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
6 |
14 |
0.0001647 |
0.001539 |
496 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
6 |
14 |
0.0001647 |
0.001539 |
497 |
NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
6 |
14 |
0.0001647 |
0.001539 |
498 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
22 |
141 |
0.0001645 |
0.001539 |
499 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
17 |
95 |
0.0001666 |
0.001554 |
500 |
NEGATIVE REGULATION OF DNA BINDING |
11 |
46 |
0.0001709 |
0.001588 |
501 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
11 |
46 |
0.0001709 |
0.001588 |
502 |
MULTICELLULAR ORGANISMAL SIGNALING |
20 |
123 |
0.0001817 |
0.001684 |
503 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
16 |
87 |
0.0001848 |
0.001709 |
504 |
FOREBRAIN CELL MIGRATION |
13 |
62 |
0.0001888 |
0.001743 |
505 |
REGULATION OF PROTEIN LOCALIZATION |
92 |
950 |
0.0001919 |
0.001768 |
506 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
21 |
133 |
0.0001937 |
0.001777 |
507 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
21 |
133 |
0.0001937 |
0.001777 |
508 |
RAS PROTEIN SIGNAL TRANSDUCTION |
22 |
143 |
0.0002025 |
0.001851 |
509 |
REGULATION OF CYTOSKELETON ORGANIZATION |
55 |
502 |
0.0002022 |
0.001851 |
510 |
PLASMA MEMBRANE ORGANIZATION |
28 |
203 |
0.0002055 |
0.001875 |
511 |
INTRACELLULAR LIPID TRANSPORT |
7 |
20 |
0.000208 |
0.001894 |
512 |
REGULATION OF INTRACELLULAR TRANSPORT |
65 |
621 |
0.0002088 |
0.001897 |
513 |
RESPONSE TO CALCIUM ION |
19 |
115 |
0.0002109 |
0.001913 |
514 |
ESTABLISHMENT OF CELL POLARITY |
16 |
88 |
0.0002121 |
0.00192 |
515 |
EXOCYTOSIS |
38 |
310 |
0.0002143 |
0.001936 |
516 |
REGULATION OF PEPTIDE TRANSPORT |
33 |
256 |
0.000216 |
0.00194 |
517 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
18 |
106 |
0.0002156 |
0.00194 |
518 |
FAT CELL DIFFERENTIATION |
18 |
106 |
0.0002156 |
0.00194 |
519 |
REGULATION OF CARTILAGE DEVELOPMENT |
13 |
63 |
0.0002235 |
0.002 |
520 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
13 |
63 |
0.0002235 |
0.002 |
521 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
36 |
289 |
0.0002267 |
0.002022 |
522 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
10 |
40 |
0.0002269 |
0.002022 |
523 |
NEURON PROJECTION REGENERATION |
9 |
33 |
0.0002284 |
0.002032 |
524 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
70 |
684 |
0.0002354 |
0.00209 |
525 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
21 |
135 |
0.0002394 |
0.002122 |
526 |
REGULATION OF BODY FLUID LEVELS |
55 |
506 |
0.0002471 |
0.002186 |
527 |
GLIOGENESIS |
25 |
175 |
0.0002552 |
0.002253 |
528 |
RESPONSE TO AXON INJURY |
11 |
48 |
0.000256 |
0.002256 |
529 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
6 |
15 |
0.0002591 |
0.002275 |
530 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
6 |
15 |
0.0002591 |
0.002275 |
531 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
12 |
56 |
0.0002667 |
0.002332 |
532 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
12 |
56 |
0.0002667 |
0.002332 |
533 |
MOTOR NEURON AXON GUIDANCE |
8 |
27 |
0.0002725 |
0.002379 |
534 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
22 |
146 |
0.000274 |
0.002387 |
535 |
RESPONSE TO PEPTIDE |
46 |
404 |
0.0002782 |
0.002418 |
536 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
17 |
99 |
0.0002785 |
0.002418 |
537 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
9 |
34 |
0.0002923 |
0.002524 |
538 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
9 |
34 |
0.0002923 |
0.002524 |
539 |
HEART VALVE DEVELOPMENT |
9 |
34 |
0.0002923 |
0.002524 |
540 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
27 |
197 |
0.0002936 |
0.00253 |
541 |
CIRCADIAN RHYTHM |
21 |
137 |
0.0002944 |
0.002532 |
542 |
REGULATION OF GLUCOSE TRANSPORT |
17 |
100 |
0.0003151 |
0.002705 |
543 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
12 |
57 |
0.0003175 |
0.002721 |
544 |
PEPTIDYL AMINO ACID MODIFICATION |
82 |
841 |
0.0003425 |
0.00293 |
545 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
10 |
42 |
0.0003486 |
0.002971 |
546 |
EPITHELIAL CELL MORPHOGENESIS |
10 |
42 |
0.0003486 |
0.002971 |
547 |
MUSCLE HYPERTROPHY |
8 |
28 |
0.0003593 |
0.003056 |
548 |
RESPONSE TO MONOAMINE |
9 |
35 |
0.0003705 |
0.003145 |
549 |
PHOSPHOLIPID METABOLIC PROCESS |
42 |
364 |
0.0003807 |
0.003227 |
550 |
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
6 |
16 |
0.0003912 |
0.00328 |
551 |
CARDIAC MYOFIBRIL ASSEMBLY |
6 |
16 |
0.0003912 |
0.00328 |
552 |
NEURON CELL CELL ADHESION |
6 |
16 |
0.0003912 |
0.00328 |
553 |
CELLULAR RESPONSE TO LEPTIN STIMULUS |
6 |
16 |
0.0003912 |
0.00328 |
554 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN |
6 |
16 |
0.0003912 |
0.00328 |
555 |
ATRIOVENTRICULAR VALVE MORPHOGENESIS |
6 |
16 |
0.0003912 |
0.00328 |
556 |
GLUCOSE HOMEOSTASIS |
24 |
170 |
0.0004011 |
0.003351 |
557 |
CARBOHYDRATE HOMEOSTASIS |
24 |
170 |
0.0004011 |
0.003351 |
558 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
16 |
93 |
0.0004073 |
0.003391 |
559 |
NEPHRON EPITHELIUM DEVELOPMENT |
16 |
93 |
0.0004073 |
0.003391 |
560 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
40 |
343 |
0.0004184 |
0.003475 |
561 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
26 |
191 |
0.000419 |
0.003475 |
562 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
13 |
67 |
0.0004225 |
0.003498 |
563 |
CEREBRAL CORTEX CELL MIGRATION |
10 |
43 |
0.0004274 |
0.003532 |
564 |
NEGATIVE REGULATION OF BINDING |
20 |
131 |
0.0004282 |
0.003533 |
565 |
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS |
5 |
11 |
0.0004324 |
0.003542 |
566 |
NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS |
5 |
11 |
0.0004324 |
0.003542 |
567 |
NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS |
5 |
11 |
0.0004324 |
0.003542 |
568 |
CARDIAC CHAMBER FORMATION |
5 |
11 |
0.0004324 |
0.003542 |
569 |
CALCIUM ION TRANSPORT |
29 |
223 |
0.0004375 |
0.003571 |
570 |
NEGATIVE REGULATION OF CELL ADHESION |
29 |
223 |
0.0004375 |
0.003571 |
571 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
14 |
76 |
0.00045 |
0.003667 |
572 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
9 |
36 |
0.000465 |
0.003749 |
573 |
GLYCEROLIPID METABOLIC PROCESS |
41 |
356 |
0.0004614 |
0.003749 |
574 |
REGULATION OF HEART MORPHOGENESIS |
8 |
29 |
0.0004674 |
0.003749 |
575 |
MUSCLE ADAPTATION |
8 |
29 |
0.0004674 |
0.003749 |
576 |
HEART PROCESS |
15 |
85 |
0.0004618 |
0.003749 |
577 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
9 |
36 |
0.000465 |
0.003749 |
578 |
NEUROBLAST PROLIFERATION |
8 |
29 |
0.0004674 |
0.003749 |
579 |
CELLULAR HOMEOSTASIS |
68 |
676 |
0.0004644 |
0.003749 |
580 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
9 |
36 |
0.000465 |
0.003749 |
581 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
27 |
203 |
0.0004757 |
0.00381 |
582 |
OVULATION CYCLE |
18 |
113 |
0.000484 |
0.00387 |
583 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
22 |
152 |
0.0004858 |
0.003877 |
584 |
NERVE DEVELOPMENT |
13 |
68 |
0.0004909 |
0.003911 |
585 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
34 |
279 |
0.0004999 |
0.003976 |
586 |
T CELL DIFFERENTIATION |
19 |
123 |
0.0005079 |
0.004033 |
587 |
REGULATION OF SODIUM ION TRANSPORT |
14 |
77 |
0.0005168 |
0.004096 |
588 |
MYELOID CELL DEVELOPMENT |
10 |
44 |
0.0005204 |
0.004118 |
589 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
22 |
153 |
0.0005323 |
0.004205 |
590 |
INNERVATION |
7 |
23 |
0.0005512 |
0.004347 |
591 |
RESPONSE TO INSULIN |
27 |
205 |
0.0005554 |
0.004373 |
592 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
6 |
17 |
0.0005706 |
0.004462 |
593 |
ANATOMICAL STRUCTURE ARRANGEMENT |
6 |
17 |
0.0005706 |
0.004462 |
594 |
NEGATIVE REGULATION OF ANOIKIS |
6 |
17 |
0.0005706 |
0.004462 |
595 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
6 |
17 |
0.0005706 |
0.004462 |
596 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
28 |
216 |
0.000573 |
0.004473 |
597 |
CORONARY VASCULATURE DEVELOPMENT |
9 |
37 |
0.0005784 |
0.004493 |
598 |
REGULATION OF MUSCLE HYPERTROPHY |
9 |
37 |
0.0005784 |
0.004493 |
599 |
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
9 |
37 |
0.0005784 |
0.004493 |
600 |
CELL CYCLE ARREST |
22 |
154 |
0.0005827 |
0.004519 |
601 |
RENAL TUBULE DEVELOPMENT |
14 |
78 |
0.0005918 |
0.004581 |
602 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
8 |
30 |
0.0006004 |
0.004627 |
603 |
CELLULAR RESPONSE TO ALCOHOL |
18 |
115 |
0.0006006 |
0.004627 |
604 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
8 |
30 |
0.0006004 |
0.004627 |
605 |
SPROUTING ANGIOGENESIS |
10 |
45 |
0.0006295 |
0.004834 |
606 |
ENDOCHONDRAL BONE MORPHOGENESIS |
10 |
45 |
0.0006295 |
0.004834 |
607 |
REGULATION OF FAT CELL DIFFERENTIATION |
17 |
106 |
0.0006338 |
0.004846 |
608 |
NEURON PROJECTION EXTENSION |
11 |
53 |
0.0006353 |
0.004846 |
609 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
11 |
53 |
0.0006353 |
0.004846 |
610 |
MESONEPHRIC TUBULE MORPHOGENESIS |
11 |
53 |
0.0006353 |
0.004846 |
611 |
NEURAL PRECURSOR CELL PROLIFERATION |
13 |
70 |
0.0006561 |
0.004988 |
612 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
13 |
70 |
0.0006561 |
0.004988 |
613 |
GLAND MORPHOGENESIS |
16 |
97 |
0.0006599 |
0.005009 |
614 |
RESPONSE TO CORTICOSTEROID |
24 |
176 |
0.0006679 |
0.005062 |
615 |
OVULATION CYCLE PROCESS |
15 |
88 |
0.0006754 |
0.00511 |
616 |
REGULATION OF HORMONE SECRETION |
32 |
262 |
0.0006929 |
0.005234 |
617 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
5 |
12 |
0.0007006 |
0.005283 |
618 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
9 |
38 |
0.0007136 |
0.005372 |
619 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
35 |
296 |
0.0007252 |
0.005451 |
620 |
REGULATION OF MYELOID CELL APOPTOTIC PROCESS |
7 |
24 |
0.0007337 |
0.005488 |
621 |
AMMONIUM TRANSMEMBRANE TRANSPORT |
7 |
24 |
0.0007337 |
0.005488 |
622 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
7 |
24 |
0.0007337 |
0.005488 |
623 |
REGULATION OF RECEPTOR ACTIVITY |
18 |
117 |
0.0007405 |
0.005531 |
624 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
41 |
365 |
0.0007619 |
0.005681 |
625 |
HINDBRAIN DEVELOPMENT |
20 |
137 |
0.0007691 |
0.005726 |
626 |
AGING |
32 |
264 |
0.0007891 |
0.005866 |
627 |
QUATERNARY AMMONIUM GROUP TRANSPORT |
6 |
18 |
0.0008078 |
0.005995 |
628 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
23 |
168 |
0.0008096 |
0.005998 |
629 |
MESODERM DEVELOPMENT |
18 |
118 |
0.0008204 |
0.006069 |
630 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
16 |
99 |
0.0008298 |
0.006119 |
631 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
16 |
99 |
0.0008298 |
0.006119 |
632 |
REGULATION OF PHOSPHATASE ACTIVITY |
19 |
128 |
0.0008383 |
0.006172 |
633 |
PLACENTA DEVELOPMENT |
20 |
138 |
0.0008442 |
0.006205 |
634 |
REGULATION OF WNT SIGNALING PATHWAY |
36 |
310 |
0.000855 |
0.006275 |
635 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
79 |
829 |
0.0008572 |
0.006281 |
636 |
REGULATION OF AXON GUIDANCE |
9 |
39 |
0.0008734 |
0.006379 |
637 |
COCHLEA DEVELOPMENT |
9 |
39 |
0.0008734 |
0.006379 |
638 |
REGULATION OF BLOOD PRESSURE |
23 |
169 |
0.0008793 |
0.006413 |
639 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
11 |
55 |
0.0008822 |
0.006424 |
640 |
SEX DIFFERENTIATION |
32 |
266 |
0.0008969 |
0.006521 |
641 |
REGULATION OF JNK CASCADE |
22 |
159 |
0.0009019 |
0.006547 |
642 |
REGULATION OF ION HOMEOSTASIS |
26 |
201 |
0.0009133 |
0.006619 |
643 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
16 |
100 |
0.0009279 |
0.006714 |
644 |
SALIVARY GLAND DEVELOPMENT |
8 |
32 |
0.0009576 |
0.006887 |
645 |
ENDOCARDIAL CUSHION DEVELOPMENT |
8 |
32 |
0.0009576 |
0.006887 |
646 |
REGULATION OF ORGAN FORMATION |
8 |
32 |
0.0009576 |
0.006887 |
647 |
EMBRYONIC FORELIMB MORPHOGENESIS |
8 |
32 |
0.0009576 |
0.006887 |
648 |
LUNG CELL DIFFERENTIATION |
7 |
25 |
0.0009608 |
0.006889 |
649 |
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
25 |
0.0009608 |
0.006889 |
650 |
REGULATION OF RESPONSE TO STRESS |
128 |
1468 |
0.0009794 |
0.007011 |
651 |
HIPPOCAMPUS DEVELOPMENT |
13 |
73 |
0.0009903 |
0.007071 |
652 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
14 |
82 |
0.0009908 |
0.007071 |
653 |
REGULATION OF SYNAPTIC PLASTICITY |
20 |
140 |
0.001014 |
0.007222 |
654 |
REGULATED EXOCYTOSIS |
28 |
224 |
0.001016 |
0.007231 |
655 |
RESPONSE TO EXTRACELLULAR STIMULUS |
47 |
441 |
0.001028 |
0.007299 |
656 |
FATTY ACID TRANSPORT |
11 |
56 |
0.001033 |
0.007325 |
657 |
FORELIMB MORPHOGENESIS |
9 |
40 |
0.001061 |
0.007515 |
658 |
REGENERATION |
22 |
161 |
0.001067 |
0.007542 |
659 |
REGULATION OF VASCULOGENESIS |
5 |
13 |
0.001076 |
0.007552 |
660 |
DIGESTIVE TRACT MORPHOGENESIS |
10 |
48 |
0.001075 |
0.007552 |
661 |
MYOFIBRIL ASSEMBLY |
10 |
48 |
0.001075 |
0.007552 |
662 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
10 |
48 |
0.001075 |
0.007552 |
663 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT |
10 |
48 |
0.001075 |
0.007552 |
664 |
INNER EAR MORPHOGENESIS |
15 |
92 |
0.001086 |
0.007611 |
665 |
POSITIVE REGULATION OF ION TRANSPORT |
29 |
236 |
0.001095 |
0.00766 |
666 |
NEGATIVE REGULATION OF AXONOGENESIS |
12 |
65 |
0.001104 |
0.007712 |
667 |
ION TRANSPORT |
112 |
1262 |
0.001108 |
0.007728 |
668 |
NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
6 |
19 |
0.001114 |
0.007728 |
669 |
PROTEIN STABILIZATION |
19 |
131 |
0.001114 |
0.007728 |
670 |
NEGATIVE REGULATION OF ATP METABOLIC PROCESS |
6 |
19 |
0.001114 |
0.007728 |
671 |
ATRIOVENTRICULAR VALVE DEVELOPMENT |
6 |
19 |
0.001114 |
0.007728 |
672 |
REGULATION OF LIPASE ACTIVITY |
14 |
83 |
0.00112 |
0.007755 |
673 |
LIPID METABOLIC PROCESS |
104 |
1158 |
0.001122 |
0.007755 |
674 |
REGULATION OF SECRETION |
68 |
699 |
0.001132 |
0.007817 |
675 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
16 |
102 |
0.001154 |
0.007953 |
676 |
EMBRYONIC AXIS SPECIFICATION |
8 |
33 |
0.001191 |
0.008161 |
677 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
21 |
152 |
0.001189 |
0.008161 |
678 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
21 |
152 |
0.001189 |
0.008161 |
679 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
8 |
33 |
0.001191 |
0.008161 |
680 |
EAR MORPHOGENESIS |
17 |
112 |
0.001196 |
0.008187 |
681 |
AMMONIUM TRANSPORT |
11 |
57 |
0.001204 |
0.008225 |
682 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
18 |
122 |
0.001218 |
0.008297 |
683 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
18 |
122 |
0.001218 |
0.008297 |
684 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
9 |
41 |
0.00128 |
0.008708 |
685 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
13 |
75 |
0.001284 |
0.00871 |
686 |
CELLULAR GLUCOSE HOMEOSTASIS |
13 |
75 |
0.001284 |
0.00871 |
687 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
21 |
153 |
0.001294 |
0.008762 |
688 |
RESPONSE TO OXIDATIVE STRESS |
39 |
352 |
0.001307 |
0.008837 |
689 |
REGULATION OF LEUKOCYTE PROLIFERATION |
26 |
206 |
0.001312 |
0.008858 |
690 |
REPRODUCTION |
114 |
1297 |
0.001402 |
0.009454 |
691 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
26 |
207 |
0.001407 |
0.009476 |
692 |
POSITIVE REGULATION OF PROTEIN IMPORT |
16 |
104 |
0.001424 |
0.009576 |
693 |
REGULATION OF CATABOLIC PROCESS |
70 |
731 |
0.001458 |
0.009773 |
694 |
MULTICELLULAR ORGANISM GROWTH |
13 |
76 |
0.001456 |
0.009773 |